middle.news
Genetic Signatures Accelerates US Push with 71% Sales Surge and Automation Drive
4:44am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Genetic Signatures Accelerates US Push with 71% Sales Surge and Automation Drive
4:44am on Monday 2nd of June, 2025 AEST
Key Points
Quarterly sales rose 71% to $2.9 million, driven by respiratory testing in Australia
First US commercial contract signed for EasyScreen Gastrointestinal Parasite Detection Kit
New automation and customisation strategy implemented to reduce development time and costs
Strong cash position with $37.4 million at quarter end
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
GENETIC SIGNATURES (ASX:GSS)
OPEN ARTICLE